Accelerating Drug Discovery

Lupus Therapeutics was established to advance lupus clinical research by finding more effective and safer treatments for people living with lupus. In well over half a century only one new drug has been approved to treat this disease; this is not good enough. We are committed to finding and illuminating promising new treatment opportunities, and ultimately delivering them to lupus patients in just years, not decades.

This is an aspirational investment that we invite every stakeholder in the lupus community to take part in—patients, doctors, researchers and industry.

Lupus Clinical Investigators Network (LuCIN) Site Locations

LuCIN is an academic-based clinical trials network comprised of some of the most prestigious medical research centers and experienced lupus physician-scientists throughout North America.

Click on State or Province to zoom. Click on the site location for more information.

Watch this video to learn more about Lupus Therapeutics and
find out why it will bring us better treatments for lupus faster.

Lupus Therapeutics News

Stelara® and Olumiant® Considered...

February 19, 2019 In Healio Rheumatology, Dr. Gregg Silverman, professor of medicine and pathology at NYU School of Medicine, provided an overview...

Read More

Lupus Therapeutics Launches Peer...

February 1, 2019 Today, Lupus Therapeutics, an affiliate of Lupus Research Alliance, is launching our Patient Advocates for Lupus Studies (PALS) program...

Read More

Lupus Research Alliance and...

February 1, 2019 The Lupus Research Alliance announced that its affiliate Lupus Therapeutics is working with the pharmaceutical company, Janssen, to help...

Read More

Contact Us

Lupus Therapeutics mission is to accelerate drug discovery and diagnostic innovation for all patients living with lupus. If you would like to learn more please contact us:

Learn more about ongoing clinical trials being conducted within LuCIN